CASI Pharmaceuticals
PublicCASI Pharmaceuticals is now publicly traded
The data on this page reflects CASI Pharmaceuticals's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Seed Round
Feb 26, 2026
Total Funding Raised
$72.5M
Company Overview
CASI Pharmaceuticals has raised $72.5M. It was founded in 1991.
CASI Pharmaceuticals is a biopharmaceutical company that develops and commercializes innovative therapeutics for cancer and other unmet medical needs.
AI Layer
Non-AI
CASI Pharmaceuticals Comparables
Compare CASI Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hangzhou Shangjian Biotechnology Co., Ltd. | 82% | |
| Zai Lab Limited | 79% | |
| InnoCare Pharma Limited | 77% |
For institutional investors. Book with your work email.
CASI Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Feb 26, 2026 | ||||
| Convertible Debt | Dec 11, 2025 | ||||
| Follow-on Offering | Dec 20, 2024 | ||||
| PIPE | Jul 15, 2024 | ||||
| Follow-on Offering | Mar 24, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CASI Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Foresite Capital | PIPE |
| Venrock | PIPE |
| Panacea Venture Healthcare | PIPE |
CASI Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.